Back to search

France· FR:60798567

ANTIBIO SYNALAR, solution pour instillation auriculaire

A medicinal product containing acétonide de fluocinolone + sulfate de polymyxine b + sulfate de néomycine, registered in France by JOLLY JATEL, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedANTIBIO SYNALAR, solution pour instil…ATC—REGISTER NO.FR:60798567PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ACÉTONIDE DE FLUOCINOLONE + SULFATE DE POLYMYXINE B + SULFATE DE NÉOMYCINE
Manufacturer
JOLLY JATEL
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930053287
    1 flacon(s) polyéthylène de 10 ml avec compte-gouttes PVC
    EUR 2

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c5da203b-b73c-477b-9be7-3f71d1abaa71
GET /v1/drugs/c5da203b-b73c-477b-9be7-3f71d1abaa71?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "60798567",
  "date_amm": "1996-06-14",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "ACÉTONIDE DE FLUOCINOLONE + SULFATE DE POLYMYXINE B + SULFATE DE NÉOMYCINE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution pour instillation",
  "voies_administration": "auriculaire",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about acétonide de fluocinolone + sulfate de polymyxine b + sulfate de néomycine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.